These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 15089797)

  • 41. Introducing a simplified approach to insulin therapy in type 2 diabetes: a comparison of two single-dose regimens of insulin glulisine plus insulin glargine and oral antidiabetic drugs.
    Lankisch MR; Ferlinz KC; Leahy JL; Scherbaum WA;
    Diabetes Obes Metab; 2008 Dec; 10(12):1178-85. PubMed ID: 19040645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study.
    Lund SS; Tarnow L; Astrup AS; Hovind P; Jacobsen PK; Alibegovic AC; Parving I; Pietraszek L; Frandsen M; Rossing P; Parving HH; Vaag AA
    PLoS One; 2008; 3(10):e3363. PubMed ID: 18852875
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care.
    Khunti K; Gray LJ; Skinner T; Carey ME; Realf K; Dallosso H; Fisher H; Campbell M; Heller S; Davies MJ
    BMJ; 2012 Apr; 344():e2333. PubMed ID: 22539172
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin.
    Malanda UL; Welschen LM; Riphagen II; Dekker JM; Nijpels G; Bot SD
    Cochrane Database Syst Rev; 2012 Jan; 1():CD005060. PubMed ID: 22258959
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fasting plasma glucose 6-12 weeks after starting insulin glargine predicts likelihood of treatment success: a pooled analysis.
    Karl D; Zhou R; Vlajnic A; Riddle M
    Diabet Med; 2012 Jul; 29(7):933-6. PubMed ID: 22413808
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of the availability of inhaled insulin on glycaemic control in patients with Type 2 diabetes failing on oral therapy: the evaluation of Exubera as a therapeutic option on insulin initiation and improvement in glycaemic control in clinical practice (EXPERIENCE) trial.
    Del Prato S; Blonde L; Martinez L; Göke B; Woo V; Millward A; Gomis R; Canovatchel B; Strack T; Lawrence D; Freemantle N;
    Diabet Med; 2008 Jun; 25(6):662-70. PubMed ID: 18435781
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequency of blood glucose monitoring in relation to glycemic control in patients with type 2 diabetes.
    Harris MI;
    Diabetes Care; 2001 Jun; 24(6):979-82. PubMed ID: 11375356
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structured patient education: the diabetes X-PERT Programme makes a difference.
    Deakin TA; Cade JE; Williams R; Greenwood DC
    Diabet Med; 2006 Sep; 23(9):944-54. PubMed ID: 16922700
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determinants of glycaemic control in type 1 diabetes during intensified therapy with multiple daily insulin injections or continuous subcutaneous insulin infusion: importance of blood glucose variability.
    Pickup JC; Kidd J; Burmiston S; Yemane N
    Diabetes Metab Res Rev; 2006; 22(3):232-7. PubMed ID: 16389648
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).
    Kanazawa Y; Igarashi Y; Komiya K; Sakurai Y; Shimizu T; Fujitani Y; Tanaka Y; Watada H; Kawamori R; Hirose T
    Endocr J; 2007 Dec; 54(6):975-83. PubMed ID: 18000343
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Costs of therapy of insulin-treated patients with Diabetes mellitus in Germany. Results of the JEVIN trial].
    Schiel R; Müller UA; Stein G
    Med Klin (Munich); 2005 Aug; 100(8):453-61. PubMed ID: 16096726
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intensification of diabetes medication and risk for 30-day readmission.
    Wei NJ; Wexler DJ; Nathan DM; Grant RW
    Diabet Med; 2013 Feb; 30(2):e56-62. PubMed ID: 23126686
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Field test of a group education program for type 2 diabetes: measures and predictors of success on individual and group levels.
    Sarkadi A; Rosenqvist U
    Patient Educ Couns; 2001 Aug; 44(2):129-39. PubMed ID: 11479053
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Glycaemic control and implementation of the ADA/EASD-2006 consensus algorithm in type 2 diabetes mellitus patients in primary care in Spain.
    Alvarez-Guisasola F;
    Int J Clin Pract; 2014 Jan; 68(1):28-39. PubMed ID: 24341300
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sensor-augmented pump therapy lowers HbA(1c) in suboptimally controlled Type 1 diabetes; a randomized controlled trial.
    Hermanides J; Nørgaard K; Bruttomesso D; Mathieu C; Frid A; Dayan CM; Diem P; Fermon C; Wentholt IM; Hoekstra JB; DeVries JH
    Diabet Med; 2011 Oct; 28(10):1158-67. PubMed ID: 21294770
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
    Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
    Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of an empowerment education programme. A randomized study in teenagers with diabetes.
    Viklund G; Ortqvist E; Wikblad K
    Diabet Med; 2007 May; 24(5):550-6. PubMed ID: 17367306
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inequalities in glycaemic control in patients with Type 2 diabetes in primary care.
    Bebb C; Kendrick D; Stewart J; Coupland C; Madeley R; Brown K; Burden R; Sturrock N
    Diabet Med; 2005 Oct; 22(10):1364-71. PubMed ID: 16176198
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus.
    Al Mazroui NR; Kamal MM; Ghabash NM; Yacout TA; Kole PL; McElnay JC
    Br J Clin Pharmacol; 2009 May; 67(5):547-57. PubMed ID: 19552750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine.
    Doyle EA; Weinzimer SA; Steffen AT; Ahern JA; Vincent M; Tamborlane WV
    Diabetes Care; 2004 Jul; 27(7):1554-8. PubMed ID: 15220227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.